Interní Med. 2002; 4(6): 29-34

Následná terapie po prodělaném ischemickém iktu

MUDr. David Školoudík1, MUDr. Michal Bar1, MUDr. Daniel Václavík2, MUDr. Ondřej Škoda3
1 Neurologická klinika FNsP Ostrava-Poruba
2 Neurologické oddělení VN BMA Ostrava
3 Neurologické oddělení nemocnice Pelhřimov

Keywords: cerebral ischemia, antiplatelet therapy, anticoagulant therapy, endarterectomy, rehabilitation, secondary prevention.

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Školoudík D, Bar M, Václavík D, Škoda O. Následná terapie po prodělaném ischemickém iktu. Interní Med. 2002;4(6):29-34.

V článku jsou shrnuty současné poznatky a jednotlivé terapeutické postupy u pacientů po ischemické cévní mozkové příhodě. Správná terapie po prodělaném iktu obsahuje všechny následující postupy, tedy farmakologickou i nefarmakologickou sekundární prevenci a zároveň správnou léčbu následků iktu. V první části je probrána sekundárně preventivní péče. Podle etiopatogeneze iktu jsou zde rozebrány jednotlivé indikace antiagregační, antikoagulační a chirurgické terapie. Nezbytnou součástí sekundární prevence je diagnostika a terapie ovlivnitelných rizikových faktorů. V další části se zabýváme léčbou následků iktu, tedy především rehabilitační, logopedickou, psychologickou a symptomatickou terapií.

Management of patients after ischemic stroke

The article summarizes current knowledge and particular therapeutic approaches in management of patients after stroke. Correct management of patients after stroke consists of both pharmacological and nonpharmacological secondary prevention and, at the same time, of appropriate treatment of stroke consequences. The first part of this article concentrates onto secondary preventive care. Due to ethiopatogenesis of stroke, the indications of antiplatelet therapy, anticoagulant therapy and surgical treatment are discussed here. The essential part of the secondary prevention involves diagnosis and treatment of affectable risk factors. The other part deals with the therapy of stroke sequelae, that comprises of rehabilitation, logopedics, psychological and symptomatic therapy.

Neurologická klinika FNsP Ostrava-Poruba

Neurologické oddělení VN BMA Ostrava

Neurologické oddělení nemocnice Pelhřimov

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and trombolytic therapy for ischemic stroke. Chest 2001; 119(suppl.1): 309-320. Go to original source... Go to PubMed...
    2. Antiplatelet Trialists´ Collaboration. Collaborative overwiew of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106. Go to original source... Go to PubMed...
    3. Biller J, Feinberg W, Castaldo J, Whittemore A, Harbaugh R, Dempsey R, Caplan L, et al. Guidlines for carotid endarterektomy. A statement for healthcare professionals from a special writting group of the Stroke Council, American Heart Association. Stroke 1998; 97: 501-509. Go to original source... Go to PubMed...
    4. Bogousslavsky J, Kaste M, Olsen TS, Hacke W, Orgogozo JM. Risk factors and stroke prevention. Cerebrovasc Dis 2000; 10(suppl.3): 12-21. Go to original source... Go to PubMed...
    5. Blaw G, Lagay A, Smelt A, Westerndorp R. Stroke, statins and cholesterol: A meta-analysis of randomized, placebo-controlled, double-blind trials with HMC-CoA Reductase inhibitors. Stroke 1997; 28: 946-950. Go to original source... Go to PubMed...
    6. Cannegieter S, Rosendaal F, Witzen A, van der Meer F, Vandenbroucke J, Briët E. Optimal oral anticoagulation therapy in patients with machanical heart valves. N Engl J Med 1995; 333: 11-17. Go to original source... Go to PubMed...
    7. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-1339. Go to original source... Go to PubMed...
    8. Chimowitz M, Kokkinos J, Strong J, Brown M, Levine S, Silliman S. The warfarin-aspirin symptomatic intracranial disease study group. Neurology 1995; 45:1488-1493. Go to original source... Go to PubMed...
    9. Diener H, Cunha L, Forbes C, Silvenius J, Smets P, Lowenthal A. European stroke prevention study 2, dipyridamole and acetylsalicylic acid in the secondary pravention of stroke. J Neurol Sci 1996; 143: 1-13. Go to original source... Go to PubMed...
    10. Ehler E. Současná terapie spasticity se zaměřením na lokální aplikaci Botulotoxinu. Neurologie pro praxi 2001; 3: 128-132.
    11. Gent M, Blakely J, Easton D, Ellis D, Hachinski W, Harbisson J, et al. The Canadian American Ticlopidine Study (CATS) in trombembolic stroke. Lancet 1989; i: 1215-1220. Go to original source... Go to PubMed...
    12. Gil-Peralta A, Mayol A, Marcos J, Gonzales A, Ruano J, Boza F, et al. Percutaneous transluminal angioplasty of the symptomatic atherosclerotic carotid arteries, results, complications and follow up. Stroke 1996; 27: 2271-2273. Go to original source... Go to PubMed...
    13. Hart R, Sherman D, Easton D, Cairns J. Prevention of stroke in patients with nonvalvular atrial fibrillation: View and reviews. Neurology 1998; 51: 674-681. Go to original source... Go to PubMed...
    14. Laupacis A, Albers G, Dalen J, Dunn M, Jacobson A, Singer D. Antithrombotic therapy in atrial fibrillation. Chest 1998; 114: 579-589. Go to original source... Go to PubMed...
    15. Lee I, Hennekens C, Berger KI, Buring J, Manson J, Exercise and risk of stroke in male physicians. Stroke 1999; 30: 1-6. Go to original source... Go to PubMed...
    16. Pfeiffer J. Facilitační metody v léčebné rehabilitaci. Avicenum Praha 1976: 267.
    17. Pfeiffer J. Ergoterapie II. Avicenum Praha 1990: 169.
    18. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-preassure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2001; 358: 1033-1041. Go to original source... Go to PubMed...
    19. Sacco R, Elkind M, Boden-Alba B, Lin I, Kargmann D, Hauser W, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999; 281: 53-60. Go to original source... Go to PubMed...
    20. The Dutch TIA Trial Study Group A comparison of two doses of aspirin (30mg vs. 283 mg a day) in patients after transient ischemic attack or a minor ischemic stroke. N Engl J Med 1991; 325: 1261-1266.
    21. The IC/EC Bypass Study Group Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke, results of an international randomized trial. N Engl J Med 1985; 313: 1191-1200.
    22. The European Atrial Fibrillation Study Group. Optimal oral anticoagulation therapy with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995; 333: 5-10. Go to original source... Go to PubMed...
    23. Votava J. Rehabilitace osob po cévní mozkové příhodě. Neurologie pro praxi 2001; 4: 184-189.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.